Jim Cramer Just Can’t Stop Praising Johnson & Johnson (JNJ)

We recently published 15 Fresh Stocks Jim Cramer Discussed.  Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed. Jim Cramer has turned quite optimistic on pharmaceutical firm Johnson & Johnson (NYSE:JNJ) lately. Most of the CNBC TV host’s optimism stems from the firm’s cancer drug portfolio and its decision to spin off its orthopaedic business. The shares have gained 47.8% over the past year and by 5.5% year-to-date. Early in January, Bernstein raised Johnson & Johnson (NYSE:JNJ)’s sha ...